According to newspaper reports, Nicholas Piramal Limited is conducting advanced human trials on an anti-cancer and anti-infective drug. Patents have been filed in the US and India. The research and development (R&D) efforts have been jointly undertaken with Cytran Inc., US.
Nicholas Piramal Limited is one of the largest pharmaceutical companies in India, commanding a combined market share of 5%. The company has a strong presence in anti-bacterials, cardiovusculars, opthalmics, vitamins, biotek and antacids. It is the only Indian firm that is a part of the Massachusetts Institute of Technology's industrial liaison programme.
Indian pharmaceutical companies have been stepping up their R&D efforts in view of the Year 2005 deadline set by the WTO for the recognition of product patents in the country. Companies including Ranbaxy and Dr Reddy's have already achieved a significant measure of success in their efforts, with Cipla following closely. The companies have been developing products and also concentrating on their generic drugs business, which they expect, will continue to rake in profits due to the competitive advantages Indian firms enjoy. The success of its R&D efforts will propel Nicholas Piramal into this select group of Indian pharmaceutical companies.
For the quarter ended June 2020, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 22.1% YoY). Sales on the other hand came in at Rs 29 bn (down 16.2% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.
For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.
Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
This could take India to the position of 3rd largest economy.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
This ignored sector could deliver big short-term profits.
More
Equitymaster requests your view! Post a comment on "Nicholas Piramal's R&D efforts bear fruit". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!